Trial
NCT02137837
S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
SWOG Cancer Research Network
Collaborators
AstraZeneca; Novartis
Condition
Breast Cancer
Intervention
Fulvestrant
Why stopped
lack of accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-01-28